The Naval Medical Research Center Clinical Trials Center supports the Navy Medicine Research and Development mission to test preventative vaccines against militarily relevant infectious diseases. Established in 1999, the CTC celebrated it's 18th anniversary in September, 2017.
The NMRC CTC is staffed with research physicians, clinical research nurses, project managers/research coordinators, a recruiter, a quality assurance officer, a data specialist and ancillary staff members to execute its mission. The facility has over 3500 square feet of area that accommodates offices and work spaces for the research staff as well as a vaccine preparation room, subject evaluation rooms, a phlebotomy laboratory, a reception/waiting area, and a record retention/storage room.
The clinical trials at the NMRC CTC are conducted according to study-specific protocols and in compliance with International Conference on Harmonization (ICH) Good Clinical Practice (GCP), Belmont Principles, and other applicable regulatory and Department of Defense (DoD) requirements. All study personnel carry out their responsibilities in accordance with ICH GCP guidelines and clinic site standard operating procedures (SOPs).
The NMRC CTC has the capability to support Investigational New Drug (IND) applications for experimental vaccine products. The research staff has extensive experience in protocol development, clinical project management and execution of established SOPs to support IND submissions to the Federal Drug Administration for licensing vaccine products. The CTC also has the capacity to conduct leukapheresis, a laboratory procedure in which white blood cells are separated from whole blood. This capability helps to make the CTC a leading center for research on the development of vaccines to protect against malaria and other infectious diseases.